287
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Sensitivity analysis of parameters and methodological choices used in calculation of radiation detriment for solid cancer

ORCID Icon, ORCID Icon, , ORCID Icon, , & show all
Pages 596-605 | Received 28 Aug 2019, Accepted 11 Dec 2019, Published online: 21 Jan 2020

References

  • Breckow J, Emami S, Amalhaf S, Beshgard A, Buermeyer J, Spruck K. 2018. Impact of updating the non-radiation parameters in the ICRP 103 detriment model. Radiat Environ Biophys. 57(2):89–98.
  • Brenner AV, Preston DL, Sakata R, Sugiyama H, Berrington de Gonzalez A, French B, Utada M, Cahoon EK, Sadakane A, Ozasa K, et al. 2018. Incidence of breast cancer in the Life Span Study of Atomic Bomb Survivors; 1958–2009. Radiat Res. 190(4):433–444.
  • Chen A, Jacobsen KH, Deshmukh AA, Cantor SB. 2015. The evolution of the disability-adjusted life year (DALY). Socioecon Plann Sci. 49(C):10–15.
  • Cléro E, Vaillant L, Hamada N, Zhang W, Preston D, Laurier D, Ban N. 2019. History of radiation detriment and its calculation methodology used in ICRP Publication 103. J Radiol Prot. 39(3):R19–R36.
  • ICRP. 1991. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21(1–3).
  • ICRP. 1992. The Biological Basis for Dose Limitation in the Skin. ICRP Publication 59. Ann. ICRP 22(2).
  • ICRP. 2006. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99.
  • ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37 (2–4).
  • Kocher DC, Apostoaei AI, Hoffman FO, Trabalka JR. 2018. Probability distribution of dose and dose-rate effectiveness factor for use in estimating risks of solid cancers from exposure to low-let radiation. Health Phys. 114(6):602–622.
  • NCRP. 2018. Implications of recent epidemiologic studies for the linear-nonthreshold model and radiation protection. NCRP Commentary No. 27. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements.
  • NRC. 2006. Health risks from exposure to low levels of ionizing radiation: BEIR VII – Phase 2. National Research Council, National Academy of Sciences.
  • Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. 2002. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publications No. 155. Lyon, France: Lyon International Agency for Research on Cancer.
  • Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD. Jr. 2002. ERRATA in radiation effects on breast cancer risk: a pooled analysis of eight cohort. Radiat Res. 158:666.
  • Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. 2007. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res. 168(1):1–64.
  • Rühm W, Azizova T, Bouffler S, Cullings HM, Grosche B, Little MP, Shore RS, Walsh L, Woloschak GE. 2018. Typical doses and dose rates in studies pertinent to radiation risk inference at low doses and low dose rates. J Radiat Res. 59(Suppl 2):ii1–10.
  • Rühm W, Azizova TV, Bouffler SD, Little MP, Shore RE, Walsh L, Woloschak GE. 2016. Dose-rate effects in radiation biology and radiation protection. Ann ICRP. 45(1 Suppl):262–279.
  • Rühm W, Eidemüller M, Kaiser JC. 2017. Biologically-based mechanistic models of radiation-related carcinogenesis applied to epidemiological data. Int J Radiat Biol. 93(10):1093–1117.
  • Rühm W, Woloschak GE, Shore RE, Azizova TV, Grosche B, Niwa O, Akiba S, Ono T, Suzuki K, Iwasaki T, et al. 2015. Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection. Radiat Environ Biophys. 54(4):379–401.
  • Shimada K, Kai M. 2015. Calculating disability-adjusted life years (DALY) as a measure of excess cancer risk following radiation exposure. J Radiol Prot. 35(4):763–775.
  • Shore R, Walsh L, Azizova T, Rühm W. 2017. Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor. Int J Radiat Biol. 93(10):1064–1078.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34.
  • SSK. 2014. Dose- and dose-rate-effectiveness factor (DDREF), Recommendation by the German Commission on Radiological Protection with Scientific Grounds.
  • Thomas D, Darby S, Fagnani F, Hubert P, Vaeth M, Weiss K. 1992. Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys. 63(3):259–272.
  • Tran V, Little MP. 2017. Dose and dose rate extrapolation factors for malignant and non-malignant health endpoints after exposure to gamma and neutron radiation. Radiat Environ Biophys. 56(4):299–328.
  • U.S. DHHS. 1989. Cancer statistics review 1973–86 including a report on the status of cancer control. NIH Publication No. 89-2789. Bethesda, Maryland: US Department of Health and Human Services, PHS, NIH, NCI.
  • UNSCEAR. 2008. Effects of ionizing radiation. Volume I: Report to the General Assembly, Scientific Annexes A and B. UNSCEAR 2006 Report. United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations sales publication E.08.IX.6. United Nations, New York.
  • UNSCEAR. 2015. Sources, effects and risks of ionizing radiation. Report to the General Assembly and Scientific Annexes A and B. UNSCEAR 2012 Report. United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations sales publication E.16.IX.1. United Nations, New York.
  • Wakeford R, Azizova T, Dörr W, Garnier-Laplace J, Hauptmann M, Ozasa K, Rajaraman P, Sakai K, Salomaa S, Sokolnikov M, et al. 2019. The dose and dose-rate effectiveness factor (DDREF). Health Phys. 116(1):96–99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.